FDA Inspection 768491 — Cipla Ltd.
The FDA completed an inspection of Cipla Ltd. on November 17, 2011 in Bangalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 17, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bangalore (India)